Tri Locum Partners’s Travere Therapeutics TVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-251,702	Closed	-$2.25M	–	54
2023 Q3	$2.25M	Buy	+251,702	New	+$2.25M	0.72%	33
2022 Q3	–	Sell	-162,014	Closed	-$3.93M	–	61
2022 Q2	$3.93M	Buy	+162,014	New	+$3.93M	1.61%	21